The company was formed by Scott D. Boden, MD, chief medical officer of Emory University Orthopaedic & Spine Hospital and professor of orthopedics at Emory University, and Stephen R. LaNeve, former president of a spinal and biologics division of a global medical device company. SkelRegen will focus on developing technologies for skeletal tissue formation.
More Articles on Orthopedic Devices:
37 Orthopedic & Spine Devices Receives FDA 510(k) Clearance in September
Study: Generic Implants Save Hospital Over $34,600 Annually
Lakewood Ranch Medical Center in Florida Adopts MAKOplasty
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.